STEP 370: Lipid Biomarkers and Coronary Heart Disease Part II (CE: 1.0)


This article is part two of a two-part STEP series discussing lipid biomarkers and coronary heart disease. In this article, total cholesterol (TC) levels and low-density lipoprotein cholesterol (LCL) levels are discussed. This series began in STEP 366.


Learning Objectives:

  • Describe the difference between total cholesterol and low-density lipoprotein cholesterol
  • Reflect on studies done on CAD
  • Identify when CVD risk factors emerge



David Plaut

William McLellan, MS


Launched: 2010